|
Mera Pharmaceuticals, Inc. - Comparative Business Analysis Snapshot
Business Description
Mera Pharmaceuticals, Inc.. The Company's principal activities are to develop and commercialize natural products from microalgae using the large-scale photobioreactor technology known as Mera Growth Module (MGM). Its three operations are Natural Products,Contract services and Royalties. It uses its photobioreactor technology in the production and marketing of its first commercial product, ASTAFACTOR(R), a nutraceutical & source of natural astaxanthin. Its Trademarks & Service marks are SALMONESSENTIALS, AQUAXAN, MERA PHARMACEUTICALS, MERA GROWTH MODULE, MERA PROCESS CONTROL SYSTEM, MERA REMOTE DATA WEB ACCESS & DRUGS FROM THE SEA. The microalgae are known to contain valuable substances that have existing & potential commercial applications in fields such as animal and human nutrition, food colorings, cosmetics, diagnostic products, pharmaceuticals, research grade chemicals, pigments & dyes. It operates in the United States, Korea & Malaysia.
Competitor Analysis
This analysis compares Mera Pharmaceuticals, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
